Holen Sie sich die Stockscreener-App
4.52
0.44%
0.02
Handel nachbörslich:
4.58
0.06
+1.33%
Schlusskurs vom Vortag:
$4.50
Offen:
$4.38
24-Stunden-Volumen:
3,758
Relative Volume:
0.07
Marktkapitalisierung:
$62.12M
Einnahmen:
$49.98M
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-8.0542
EPS:
-0.5612
Netto-Cashflow:
$-4.86M
1W Leistung:
+0.22%
1M Leistung:
+2.26%
6M Leistung:
-3.83%
1J Leistung:
-17.37%
1-Tages-Spanne:
$4.34
$4.58
1-Wochen-Bereich:
$4.34
$4.70
52-Wochen-Spanne:
$3.6001
$7.1303
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Vergleichen Sie CSBR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CSBR | 4.52 | 62.12M | 49.98M | -9.64M | -4.86M | -0.5612 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago - Yahoo Finance
Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth - Simply Wall St
Shangri-La Mactan champions Breast Cancer Awareness with 'Pink Path to Hope' Fun Run and Wellness Forum - SunStar Philippines
CancerX Launches Expanded Accelerator Program for 2025, Partnering With KidsX to Transform Cancer Care Innovation - 01Net
Custom Assay Development Service Market Size, Share, Growth Forecast and Trends Analysis (2024-2032) - Economica
Patient Derived Xenograft Model Market Set for Explosive Growth - openPR
Champions Oncology announces stockholder meeting results - Investing.com India
Champions Oncology secures Weill Cornell PDX models license - Investing.com
Champions Oncology secures Weill Cornell PDX models license By Investing.com - Investing.com UK
Champions Oncology Announces Agreement with Weill Cornell Medicine - AccessWire
Champions Oncology announces stockholder meeting results By Investing.com - Investing.com UK
Florida Today EventsPremier Boxing ChampionsTszyu v Murtazaliev - Florida Today
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Champions Oncology Announces Sudden Loss of President - TipRanks
Champions Oncology President Brady Davis Dies >CSBR - MarketWatch
Champions Oncology, Inc. Announces Demise of Brady Davis as President - Marketscreener.com
CN Energy Group (NASDAQ:CNEY) Stock Quotes, Forecast and News Summary - Benzinga
Patient Derived Xenograft or PDX Models Market Growth Factors & Key Statistics - Economica
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business - Yahoo Finance
Magnetar Financial LLC Buys Shares of 2,193,929 ChampionX Co. (NASDAQ:CHX) - Defense World
Its Stock Has Paid Off Big Time For Champion Homes Inc. - SETE News
P Schoenfeld Asset Management LP Makes New $5.45 Million Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Potential Price Increase for Champion Homes Inc. (SKY) After Recent Insider Activity - Knox Daily
Ameritas Investment Partners Inc. Has $1.97 Million Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
DekaBank Deutsche Girozentrale Makes New Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Renaissance Technologies LLC Takes Position in ChampionX Co. (NASDAQ:CHX) - MarketBeat
Benjamin Edwards Inc. Increases Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
622,616 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Renaissance Technologies LLC - Defense World
CHX Shares Experience Surge in Value - Knox Daily
6,878 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Choreo LLC - Defense World
ChampionX Co. (NASDAQ:CHX) Shares Sold by Oppenheimer Asset Management Inc. - Defense World
Seven Eight Capital LP Acquires Shares of 56,674 ChampionX Co. (NASDAQ:CHX) - Defense World
Mutual of America Capital Management LLC Sells 237,847 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
Victory Capital Management Inc. Sells 56,930 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
State of New Jersey Common Pension Fund D Trims Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
Cybersecurity Awareness Month Champion Organizations - National Cyber Security Alliance
Meeder Advisory Services Inc. Has $217,000 Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
Tumor Mice Model Market Detailed Summary, Industry Size and Future Growth Prospects To 2024-2032 - Cauverynews
Local official champions Blood Cancer Awareness Month to boost education - WTOV Steubenville
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - MSN
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - MSN
Champions Oncology First Quarter 2025 Earnings: EPS: US$0.097 (vs US$0.19 loss in 1Q 2024) - Simply Wall St
Champions Oncology upgraded to buy by Craig-Hallum - MSN
What is CSBR’s price-to-sales ratio telling us about the company’s value? - US Post News
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com Australia
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com India
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2024 - Marketscreener.com
Stocks to Watch: Oxford Industries, Mobile Infrastructure, Champions Oncology - MarketWatch
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):